GOLDMAN SACHS GROUP INC - CUBIST PHARMACEUTICALS INC ownership

CUBIST PHARMACEUTICALS INC's ticker is and the CUSIP is 229678AD9. A total of 36 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CUBIST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$100,000
+47.1%
29,0000.0%0.00%
Q3 2014$68,000
-1.4%
29,000
+3.6%
0.00%
Q2 2014$69,000
-4.2%
28,0000.0%0.00%
Q1 2014$72,000
+5.9%
28,0000.0%0.00%
Q4 2013$68,000
+38.8%
28,000
+27.3%
0.00%
Q3 2013$49,000
-78.8%
22,000
-83.3%
0.00%
Q2 2013$231,000
-30.2%
132,000
-37.4%
0.00%
Q4 2012$331,000
+366.2%
211,000
+414.6%
0.00%
Q3 2012$71,000
-94.3%
41,000
-95.3%
0.00%
-100.0%
Q2 2012$1,249,000868,0000.00%
Other shareholders

There were no reported owners of CUBIST PHARMACEUTICALS INC in Q2 2014.

NameSharesValueWeighting ↓
View complete list of CUBIST PHARMACEUTICALS INC shareholders